Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl.
BACKGROUND: The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protecti...
Main Authors: | Guanyu Wang, Jiawei Zhang, Luying Liu, Sherven Sharma, Qinghua Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3519886?pdf=render |
Similar Items
-
Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.
by: Fariba Némati, et al.
Published: (2014-01-01) -
Role of Autophagy in BCL-2/BCL-XL Mediated G0 Arrest
by: Valentin-Santiago, Mayda
Published: (2007) -
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
by: Yonghan He, et al.
Published: (2020-07-01) -
Doxorubicin Changes Bax /Bcl-xL
Ratio, Caspase-8 and 9 in Breast Cancer Cells
by: Simin Sharifi, et al.
Published: (2015-09-01) -
Bcl-xL in neuroprotection and plasticity
by: Elizabeth Ann Jonas, et al.
Published: (2014-09-01)